Company · CIK 0001544227 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Tempest Therapeutics, Inc. · TPST
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2026 PForm 4 → | Jun 23, 4:56 pm EDT | Matthew AngelCEO and President, Director, 10% Owner | 231,482 | $2.16 | $500,001 | 231,482 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 AForm 4 → | Jun 17, 7:24 pm EDT | John D. YeeDirector | 25,000 | — | — | 25,000 | — | late |
| Jun 4, 2026 AForm 4 → | Jun 8, 6:17 pm EDT | William Drake RicheyDirector | 25,000 | — | — | 25,000 | — | |
| Mar 24, 2026 PForm 4 → | Jun 23, 4:56 pm EDT | Matthew AngelCEO and President, Director, 10% Owner | 462,964 | — | — | 231,482 | — | late |